Article
Evolution of Molecular Targets in Melanoma Treatment.
Current pharmaceutical design - 1 Jan 2020
Tran Khanh B, Buchanan Christina M, Shepherd Peter R
Abstract excerpt
Melanoma is the deadliest type of skin cancers, accounting for more than 80% of skin cancer mortality. Although melanoma was known very early in the history of medicine, treatment for this disease had remained largely the same until very recently. Previous treatment options, including removal surgery and systemic chemotherapy, offered little benefit in extending the survival of melanoma patients. However, the...
Topics
- Antineoplastic Agents, Immunological
- Humans
- Immunotherapy
- Melanoma
- Mutation
- Protein Kinase Inhibitors
- Skin Neoplasms